Showing results (131-140 of 532) with videos related to
Sort By:
Pageof 54
Journal of Clinical Microbiology|April 1, 1983
Value of routine aerobic subculturing of unvented blood culture bottlesM A Pfaller, L M Westfall, P R MurrayAntimicrobial Agents and Chemotherapy|November 1, 1982
Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolatesM A Pfaller, J J Segal, D J KrogstadAmerican Journal of Clinical Pathology|October 1, 1984
Evaluation of the Kirby-Bauer disc diffusion test as a screening test for high-level aminoglycoside resistance in enterococciM A Pfaller, A C Niles, P R MurrayAnnals of Internal Medicine|January 1, 1989
Coagulase-negative staphylococcal bacteremia. Mortality and hospital stayM A Martin, M A Pfaller, R P WenzelClinical Microbiology Reviews|April 15, 2006
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingM A Pfaller, D J Diekema, D J SheehanEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1993
Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial speciesA L Barry, M A Pfaller, P C FuchsAntimicrobial Agents and Chemotherapy|April 1, 1993
Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399M A Pfaller, A L Barry, P C FuchsThe Journal of Antimicrobial Chemotherapy|March 1, 1993
Dirithromycin disc susceptibility tests: interpretative criteria and quality control parametersA L Barry, M A Pfaller, P C FuchsJournal of Clinical Microbiology|July 1, 1996
Strain variation among and antifungal susceptibilities of isolates of Candida kruseiY F Berrouane, R J Hollis, M A PfallerPharmacotherapy|June 10, 1998
Update on clinical antifungal susceptibility testing for Candida speciesR E Lewis, M E Klepser, M A PfallerPageof 54